2010
DOI: 10.1016/j.transproceed.2010.02.009
|View full text |Cite
|
Sign up to set email alerts
|

Exclusions and Deaths on the Liver Transplant Waiting List

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
3
0
1

Year Published

2010
2010
2018
2018

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(4 citation statements)
references
References 10 publications
0
3
0
1
Order By: Relevance
“…Firstly, patient populations of those studies comprised only of patients who qualified for a liver transplant [6,7]. Secondly, they were followed up for relatively shorter time periods [7].…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…Firstly, patient populations of those studies comprised only of patients who qualified for a liver transplant [6,7]. Secondly, they were followed up for relatively shorter time periods [7].…”
Section: Resultsmentioning
confidence: 99%
“…Firstly, patient populations of those studies comprised only of patients who qualified for a liver transplant [6,7]. Secondly, they were followed up for relatively shorter time periods [7]. Finally, the use of Kaplan –Meier survival curves is suboptimal in that situation as multiple outcomes which affect one another, namely, transplantation and death, have to be considered [6].…”
Section: Resultsmentioning
confidence: 99%
“…A implementação do MELD, ou seja, do modelo para doença hepática em estágio final como um sistema de alocação de órgãos tem reduzido a mortalidade em fila de espera. 10 Diante disso, as equipes de transplante, as quais apresentam caráter multidisciplinar, têm somado esforços de seus integrantes a fim de preparar candidatos e receptores para o enfrentamento de um procedimento tão complexo como o transplante de fígado.…”
Section: Resultsunclassified
“…This decision‐analysis model was constructed using TreeAge Pro Version 2015 (TreeAge Software, Inc, Williamstown, MA, USA). Assuming each studied cohort received treatment (one prior to LT, one preemptively prior to HCV recurrence, and the other post‐LT after HCV recurrence), the probability at each decision point was determined (Table ) . Using these assumptions, a final decision point was constructed based upon the varied decision tree.…”
Section: Methodsmentioning
confidence: 99%